|
注册号: Registration number: |
ChiCTR2600125266 |
|
最近更新日期: Date of Last Refreshed on: |
2026-05-25 09:30:40 |
|
注册时间: Date of Registration: |
2026-05-25 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
从“屏幕替代”到“伙伴重建”:城市肥胖儿童健康行为生态的机制解析与家庭护理干预研究 |
|
Public title: |
From "Screen Substitution" to "Peer Reconstruction": Mechanism Analysis and Family Nursing Intervention of Health Behavior Ecology in Urban Children with Obesity |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
从“屏幕替代”到“伙伴重建”:城市肥胖儿童健康行为生态的机制解析与家庭护理干预研究 |
|
Scientific title: |
From "Screen Substitution" to "Peer Reconstruction": Mechanism Analysis and Family Nursing Intervention of Health Behavior Ecology in Urban Children with Obesity |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
谈君 |
研究负责人: |
谈君 |
|
Applicant: |
Tan Jun |
Study leader: |
Tan Jun |
|
申请注册联系人电话: Applicant telephone: |
+86 18052811320 |
研究负责人电话:
Study leader's |
+86 511 88917820 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
2390517156@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
2390517156@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国江苏省镇江市润州区电力路8号 |
研究负责人通讯地址: |
中国江苏省镇江市润州区电力路8号 |
|
Applicant address: |
No. 8, Dianli Road, Runzhou District, Zhenjiang, Jiangsu, China |
Study leader's address: |
No. 8, Dianli Road, Runzhou District, Zhenjiang, Jiangsu, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
镇江市第一人民医院 |
||
|
Applicant's institution: |
Zhenjiang First People's Hospital |
||
|
研究负责人所在单位: |
镇江市第一人民医院 |
||
|
Affiliation of the Leader: |
Zhenjiang First People's Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
【2026】KY065 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
镇江市第一人民医院医学伦理委员会 |
||
|
Name of the ethic committee: |
The Medical Ethics Committee of the First People's Hospital of Zhenjiang City |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2026-04-30 00:00:00 | ||
|
伦理委员会联系人: |
闻向梅 |
||
|
Contact Name of the ethic committee: |
Wen Xiangmei |
||
|
伦理委员会联系地址: |
中国江苏省镇江市润州区电力路8号 |
||
|
Contact Address of the ethic committee: |
No. 8, Dianli Road, Runzhou District, Zhenjiang, Jiangsu, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 511 88917729 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
wenxiangmei@126.com |
|
研究实施负责(组长)单位: |
镇江市第一人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Zhenjiang First People's Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国江苏省镇江市润州区电力路8号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 8, Dianli Road, Runzhou District, Zhenjiang, Jiangsu, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自选课题(自筹) |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-selected Project (Self-funded) |
||||||||||||||||||||||
|
研究疾病: |
儿童肥胖 |
||||||||||||||||||||||
|
Target disease: |
Childhood obesity |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
一、主要研究目的 验证“伙伴重建”家庭干预方案的有效性 通过随机对照试验,评价“伙伴重建”家庭干预方案对肥胖儿童健康行为的改善效果,主要结局指标包括:儿童日均屏幕时间(较基线减少≥30分钟);中高强度身体活动(较基线增加≥20分钟/天);屏幕伴随进食频率(较基线下降≥30%)。 2.阐明干预方案的作用机制 通过中介效应分析,验证“同伴互动机会增加→运动动机提升→健康行为改善”的理论路径,明确家庭规则执行、屏幕替代优势降低等因素在干预效果中的中介作用。 3.构建可推广的家庭护理干预模式 形成一套理论驱动、家庭可控、护士可执行的标准化“伙伴重建”家庭护理干预方案,包括《家庭干预手册》《护理人员实施指南》及配套培训课程,为基层医疗机构提供可复制的“镇江样本”。 二、次要研究目的 1.探索肥胖儿童健康行为的家庭发生机制 通过质性研究,系统揭示城市肥胖儿童“屏幕替代—同伴缺失—行为失衡”的形成过程与维持机制,识别家庭层面可干预的关键行为杠杆(≥8项)。 2.评估干预方案对肥胖相关体格指标的影响 观察干预对儿童BMI-z、腰围等次要结局指标的改善效果,评估其在体重控制方面的附加价值。 3.评价干预方案的可行性与可接受性 通过过程评价指标(评估覆盖率、干预执行率、患者依从性)及家长满意度调查,综合评估干预方案在家庭环境中的可行性和可接受性。 4.形成政策建议与推广路径 基于研究结果,提炼儿童肥胖家庭防控服务模式的核心要素,形成《儿童肥胖家庭防控服务模式推广政策建议报告》,为政府完善《全民健康体重管理行动方案》提供决策参考。 |
||||||||||||||||||||||
|
Objectives of Study: |
I. Primary Objectives Evaluate intervention effectiveness via RCT on obese children: reduce daily screen time (>=30 min), increase MVPA (>=20 min/day), and decrease screen-associated eating (>=30%). Elucidate mechanisms through mediation analysis, testing the pathway: increased peer interaction → enhanced exercise motivation → improved health behaviors. Develop a replicable nursing model ("Peer Reconstruction") including manuals, guidelines, and training courses for primary care ("Zhenjiang Sample"). II. Secondary Objectives Explore family mechanisms of childhood obesity via qualitative study: identify ≥8 modifiable behavioral leverage points in "screen substitution – peer absence – behavioral imbalance". Assess anthropometric effects: BMI-z, waist circumference. Evaluate feasibility/acceptability: process indicators (coverage, adherence, compliance) and parent satisfaction. Formulate policy recommendations and dissemination pathways for the National Health Weight Management Action Plan. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.儿童存在严重认知、语言或发育障碍; 2.明确诊断为继发性肥胖; 3.近3个月参与过系统性体重管理项目。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1.Children with severe cognitive, language, or developmental disorders; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-05-01 00:00:00至 To 2029-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-05-25 00:00:00 至 To 2029-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由不参与干预实施的统计人员使用SAS 9.4软件生成1:1随机数字表,区组长度为4 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Random sequence generated by SAS 9.4 (block size 4). Allocation concealment using sealed opaque envelopes. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
单盲,对评估者隐藏分组 |
|
Blinding: |
Single blind study with blinded-evaluators |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
采用纸质版病例记录表(CRF)与电子数据采集系统相结合的方式。纸质CRF由研究者现场填写,双人核对后录入加密Excel数据库;电子数据通过微信小程序(问卷星)收集,自动导入后台。所有数据存储在加密服务器中,仅研究团队核心成员可访问。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
A combination of paper-based Case Report Forms (CRF) and an electronic data capture system is used. The paper CRFs are completed on-site by the researchers, double-checked, and then entered into an encrypted Excel database. Electronic data are collected via a WeChat mini-program (Wenjuanxing) and automatically imported into the backend. All data are stored on an encrypted server and accessible only to core research team members. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |